These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19449149)

  • 1. Secretory phospholipase A2 in patients with coronary artery disease.
    Lima LM; Carvalho Md; da Fonseca Neto CP; Garcia JC; Sousa MO
    J Thromb Thrombolysis; 2010 Apr; 29(3):276-81. PubMed ID: 19449149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum levels of lipoprotein(a) correlated with the severity of coronary artery disease in patients submitted to angiography.
    Lima LM; Carvalho Md; Loures-Vale AA; Fernandes AP; Mota AP; Neto CP; Garcia JC; Saad JA; Souza Mde O
    Arq Bras Cardiol; 2006 Sep; 87(3):260-6. PubMed ID: 17057924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
    Boekholdt SM; Keller TT; Wareham NJ; Luben R; Bingham SA; Day NE; Sandhu MS; Jukema JW; Kastelein JJ; Hack CE; Khaw KT
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):839-46. PubMed ID: 15692105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration.
    Misso NL; Petrovic N; Grove C; Celenza A; Brooks-Wildhaber J; Thompson PJ
    Thorax; 2008 Jan; 63(1):21-6. PubMed ID: 17573441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of combination atorvastatin (40 mg) + ezetimibe (10 mg) versus atorvastatin (40 mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent.
    Azar M; Valentin E; Badaoui G; Kassab R; Sarkis A; Azar RR
    Am J Cardiol; 2011 Jun; 107(11):1571-4. PubMed ID: 21439529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
    Zhang H; Gao Y; Wu D; Zhang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
    Cai A; Li G; Chen J; Li X; Li L; Zhou Y
    BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The secretory phospholipase A2 and transport of lipids by lipoproteins in patients with the risk of cardio-vascular pathology (the system "score") of lower and average degree. The diagnostic significance of the test].
    Ameliushkina VA; Urazalina SZh; Kotkina TI; Kaba SI; Titov VN
    Klin Lab Diagn; 2012 Mar; (3):4-10. PubMed ID: 22712282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine and methylenetetrahydrofolate reductase in subjects undergoing coronary angiography.
    Lima LM; Carvalho Md; Fernandes AP; Sabino Ade P; Loures-Vale AA; da Fonseca Neto CP; Garcia JC; Saad JA; Sousa MO
    Arq Bras Cardiol; 2007 Feb; 88(2):167-72. PubMed ID: 17384833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
    May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
    Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of C-reactive protein levels to presence, extent, and severity of angiographic coronary artery disease.
    Auer J; Rammer M; Berent R; Weber T; Lassnig E; Eber B
    Indian Heart J; 2002; 54(3):284-8. PubMed ID: 12216925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Liu PY; Li YH; Tsai WC; Chao TH; Tsai LM; Wu HL; Chen JH
    Eur Heart J; 2003 Oct; 24(20):1824-32. PubMed ID: 14563341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-dimer plasma levels in NSTE-ACS patient.
    Charoensri N; Pornratanarangsi S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S39-45. PubMed ID: 21721427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sPLA2 and endothelial function: a substudy of the SPIDER-PCI trial.
    Lavi S; Thorpe K; Luca MC; Liuni A; Floras J; Horlick EM; Ing D; Osten MD; Overgaard CB; Lan J; Parker JD; Cantor WJ; Džavík V
    Can J Cardiol; 2012; 28(2):215-21. PubMed ID: 22281412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study.
    Mattsson N; Magnussen CG; Rönnemaa T; Mallat Z; Benessiano J; Jula A; Taittonen L; Kähönen M; Juonala M; Viikari JS; Raitakari OT
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1861-6. PubMed ID: 20539018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease.
    Dutour A; Achard V; Sell H; Naour N; Collart F; Gaborit B; Silaghi A; Eckel J; Alessi MC; Henegar C; Clément K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):963-7. PubMed ID: 20008021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of circulating matrix metalloproteinase-1, but not adiponectin, with advanced coronary artery disease.
    Hwang JJ; Yang WS; Chiang FT; Chen MF; Lin HJ; Huang PJ; Hsu SH; Lai SK; Wu YW
    Atherosclerosis; 2009 May; 204(1):293-7. PubMed ID: 18823886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAI-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease.
    Lima LM; Carvalho Md; Fonseca Neto CP; Garcia JC; Sousa MO
    Arq Bras Cardiol; 2011 Dec; 97(6):462-389. PubMed ID: 22011808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis.
    Saely CH; Leiherer A; Muendlein A; Vonbank A; Rein P; Geiger K; Malin C; Drexel H
    Atherosclerosis; 2016 Jan; 244():38-43. PubMed ID: 26590865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.